2 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Kari Kendra: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain Natural Killer Cell Therapy, Temozolomide - Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain | Phase 1 / Phase 2 | Recruiting | Kari Kendra | 24 | 2023-03-01 | 2026-06-11 |
| Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery selinexor, Correlative studies - Recurrent Melanoma | Phase 1 | Completed | Kari Kendra | 8 | 2014-08-22 | 2023-04-04 |
| Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer Gemcitabine, Trastuzumab, Cisplatin - Breast Cancer | Phase 2 | Completed | Kari Kendra | 10 | 2005-02-25 | 2017-12-27 |
Melanoma (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Neoplasm Metastasis (1)
Cisplatin (1) · Gemcitabine (1) · Pharmacokinetics (1) · Temozolomide (1) · Trastuzumab (1) · selinexor (1)
United States (3)